Ascendis Pharma A/S 4

SVP & PAO Mads Bodenhoff exercised 3,000 Ascendis Pharma A/S warrants at $110.00 and sold 3,000 ordinary shares at $270.19 on September 8, 2026.

On September 8, 2026, Ascendis Pharma A/S SVP & PAO Mads Bodenhoff exercised 3,000 warrants for ordinary shares at an exercise price of $110.00 per share, acquiring 3,000 ordinary shares, and on the same date sold all 3,000 resulting ordinary shares at an average price of $270.19 per share. The option exercise (coded M) was reported as an acquisition of 3,000 ordinary shares followed by a disposition of 3,000 ordinary shares (coded S), resulting in zero directly held ordinary shares after the transactions, while 3,000 warrants remained outstanding with an expiration date of October 11, 2032 and subject to the vesting schedule described in the footnote. The combined exercise cost was approximately $330,000 and the sale proceeds were approximately $810,570, implying a spread of roughly $480,570 realized through this same-day exercise-and-sell transaction.

Filing Facts

CIK

1612042

Ticker

ASND

Form

4

Source Type

fda

Accession

0001610717-26-000409

Alert Tier

6